Download full report with analyst certification and important disclosures
Oct 7 2025, 07:24 IST/BST
CVS Group
FY2025 results
- Sectors : Pharma and healthcare
- Companies : CVS Group
DAVY VIEW
CVS’s FY2025 results reflect good revenue growth and margin expansion, especially given cost headwinds. Cash generation and proceeds from the sale of the Crematoria division have reduced leverage to only 1.2x, leaving the company well placed. The Competition and Markets Authority’s (CMA) provisional decision is now due in mid-October.
